Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study
暂无分享,去创建一个
C. Roncero | M. Casas | C. Barral | L. Rodríguez-Cintas | N. Martínez-Luna | F. Eiroa-Orosa | G. Fuste | Eiroa-Orosa Francisco José
[1] M. Ferri,et al. Heroin maintenance for chronic heroin-dependent individuals. , 2011, The Cochrane database of systematic reviews.
[2] I. Maremmani,et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[3] Rosie P Cornish,et al. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database , 2010, BMJ : British Medical Journal.
[4] D. Wedekind,et al. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[5] L. Nicholls,et al. Opioid Dependence Treatment and Guidelines , 2010, Journal of managed care pharmacy : JMCP.
[6] Ayman Fareed,et al. Methadone Maintenance Dosing Guideline for Opioid Dependence, a Literature Review , 2010, Journal of addictive diseases.
[7] F. Eiroa-Orosa,et al. Effects of Psychiatric Comorbidity on Treatment Outcome in Patients Undergoing Diamorphine or Methadone Maintenance Treatment , 2010, Psychopathology.
[8] A. Bulbena,et al. Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program: An 18-Month Follow-Up Study , 2009, International journal of environmental research and public health.
[9] G. Keating,et al. Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence† , 2009, CNS drugs.
[10] T. Clausen,et al. Mortality among opiate users: opioid maintenance therapy, age and causes of death. , 2009, Addiction.
[11] R. Ali,et al. Buprenorphine for the management of opioid withdrawal. , 2009, The Cochrane database of systematic reviews.
[12] R. Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.
[13] H. Pollack,et al. Dosage patterns in methadone treatment: results from a national survey, 1988-2005. , 2008, Health services research.
[14] M. Brekke,et al. Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study , 2008, BMC public health.
[15] M. Torrens,et al. Impact of Substance Dependence and Dual Diagnosis on the Quality of Life of Heroin Users Seeking Treatment , 2008, Substance use & misuse.
[16] Jason M. White,et al. Opioid maintenance: a comparative review of pharmacological strategies , 2007, Expert opinion on pharmacotherapy.
[17] M. Torrens,et al. Psychiatric comorbidity in young heroin users. , 2006, Drug and alcohol dependence.
[18] D. D. Des Jarlais,et al. Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients , 2006, BMC public health.
[19] R. Jagsch,et al. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. , 2005, Addiction.
[20] A. Bertolini,et al. Methadone--metabolism, pharmacokinetics and interactions. , 2004, Pharmacological research.
[21] M. Krausz,et al. Significance of Comorbidity for the Long-Term Course of Opiate Dependence , 2004, European Addiction Research.
[22] M. Torrens,et al. Characteristics of Heroin Addicts Entering Methadone Maintenance Treatment: Quality of Life and Gender , 2004, Substance use & misuse.
[23] F. Cots,et al. [Methadone maintenance programs with supplementary services: a cost-effectiveness study]. , 2003, Gaceta sanitaria.
[24] J. Antó,et al. Methadone treatment in Spain, 1994. , 1999, Drug and alcohol dependence.
[25] M. Stitzer,et al. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. , 1999, JAMA.
[26] A. Mitchell,et al. Guidelines for Good Epidemiology Practices for Drug, Device, and Vaccine Research in the United States , 1996, Pharmacoepidemiology and drug safety.
[27] G. Woody,et al. Psychiatric comorbidity: prevalence in methadone maintenance treatment. , 1996, The American journal of drug and alcohol abuse.
[28] L Grönbladh,et al. Methadone-assisted rehabilitation of Swedish heroin addicts. , 1989, Drug and alcohol dependence.
[29] R. Chaisson,et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.
[30] Alisa Pearlstone,et al. Treatment practices and perceived challenges for European physicians treating opioid dependence , 2010 .
[31] C. Roncero,et al. [Concomitant lithium and methadone treatment in a bipolar patient: a case report]. , 2009, Adicciones.
[32] J. López Castro,et al. [Benzodiazepine use in a sample of patients on a treatment program with opiate derivatives (PTDO)]. , 2009, Adicciones.
[33] M. Casas Brugué,et al. [Morphine maintenance treatment in opiate dependent patients]. , 2007, Revista clinica espanola.
[34] Y. Melamed,et al. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. , 2006, The Israel journal of psychiatry and related sciences.
[35] R. Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2003, The Cochrane database of systematic reviews.
[36] D. D. Des Jarlais,et al. A randomized trial of an interim methadone maintenance clinic. , 1991, American journal of public health.
[37] R. Hubbard,et al. Treatment Outcome Prospective Study (TOPS): client characteristics and behaviors before, during, and after treatment. , 1984, NIDA research monograph.